On Thursday a major fire broke out at the Pune-based vaccine manufacturing company Serum Institute of India. The company is involved in the production of the Covid-19 Covishield vaccine, which has recently been granted an emergency use authorization in India. According to ANI reports, the fire broke out at the …
Read More »Coronavirus | Ready to Implement COVID-19 Vaccine in India: Serum Institute of India
The company has already stockpiled about 50 million doses of the vaccine. The Serum Institute of India (SII) said on Sunday that it is ready to launch the Covishield vaccine in the country in the coming weeks after receiving approval from India’s drug regulator. The Pune-based vaccine specialist has started …
Read More »‘We will probably have a very happy new year’: DCGI on the Covid-19 vaccine
New Delhi: India is likely to have a Covid-19 vaccine in the New Year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »Expert committee will consider the Serum Institute’s request for the use of emergency vaccines | India News
NEW DELHI: The Subject Matter Experts Committee (SEC) of the Indian Drug Controller will hold a meeting to consider the Serum Institute of India’s request for approval of the emergency use of its Covid-19 vaccine, said a government official . According to sources, only the Serum Institute application will be …
Read More »Oxford Covid-19 Vaccine May Become First To Get Indian Regulator Clearance For Emergency Use
With preparations underway for a possible January launch of the vaccine, India’s drug regulator is looking into the UK, which sources say may give the Oxford Covid-19 vaccine its go-ahead next week, ahead of decide to grant emergency use authorization to the Serum Institute. who is manufacturing the shots here. …
Read More »Covid-19: Serum Institute of India Will Get India Approval Shortly After UK Approval | India News
NEW DELHI: Serum Institute of India (SII) may gain emergency use approval for Covishield in India shortly after UK drug regulator MHRA gives the go-ahead to the vaccine, which officials here hope will be before Christmas. The Medicines and Healthcare Products Regulatory Agency (MHRA) is evaluating data including which dosage …
Read More »UK regulator issues allergy warning for Pfizer / BioNTech COVID-19 vaccine
By: PTI | London | December 9, 2020 8:43:41 pm An anaphylactoid reaction tends to involve a skin rash, shortness of breath, and sometimes a drop in blood pressure, and both NHS workers who experienced this are said to have a history of severe allergies and carry adrenaline pens with …
Read More »Maharashtra CM, governor will not accompany Prime Minister Modi during his visit to SII in Pune – mumbai news
Maharashtra Governor BS Koshyariand, Chief Minister Uddhav Thackeray, will not accompany Prime Minister Narendra Modi during his visit to the Pune-based Serum Institute of India (SII) on Saturday. The Office of the Chief Minister (OCM) said this in a statement. “The prime minister and the governor will not be in …
Read More »Limited use of Oxford vaccine should be available in India in late December or early January: Serum CEO
New Delhi: Hours after the promising results of the Oxford-AstraZeneca Covid vaccine were released, the executive director of the Serum Institute Of India said Monday that the company can supply up to 400 million doses of the vaccine by July 2021. Adar Poonawalla told a trade news channel that the …
Read More »Could Seek Government Approval In December, May Cost Rs 500-600: Serum CEO
Written by Prabha Raghavan | New Delhi | Updated: November 20, 2020 7:08:08 am The candidate, who is being manufactured by SII under an agreement with Oxford-AstraZeneca, is the pioneer in India’s own race to find a vaccine to defeat the novel coronavirus. (Photo of Fie) Serum Institute of India …
Read More »